Status:

COMPLETED

eMOTION Formative Study

Lead Sponsor:

University of Southern California

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Physical Inactivity

Overweight or Obesity

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The eMOTION Study is a two-part ORBIT model phase 1 trial. The first part, called the Formative Study, will assess acceptability and feasibility of a novel physical activity intervention in adults at ...

Detailed Description

The eMOTION Study is a two-part ORBIT model phase 1 trial. The first part of the eMOTION Study, the Formative Study, will iteratively test and refine the implementation of a novel treatment to manipul...

Eligibility Criteria

Inclusion

  • adults aged ≥18 years
  • residing in the United States
  • self-reported BMI ≥ 25
  • currently engaging in \< 60 minutes per week of structured physical activity
  • owning a personal smartphone device
  • residing in an area with Internet or Wi-Fi connectivity during the study period
  • able to speak and read in English
  • interested and willing to start a physical activity program
  • willing to wear a Fitbit Versa smartwatch provided by the study team everyday continuously (including at work and during physical activity), in place of any Fitbits or smartwatches they previously wore, for the duration of the study period
  • able to read the small font on a smartwatch screen without glasses, or willing to carry reading glasses during physical activity for the purpose of reading the smartwatch screen

Exclusion

  • unable to provide informed consent due to cognitive disability
  • unable to engage in one or more key treatment components, including those with medical conditions that preclude physical activity engagement or who cannot wear an accelerometer on the wrist for any reason
  • currently pregnant

Key Trial Info

Start Date :

October 6 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2024

Estimated Enrollment :

47 Patients enrolled

Trial Details

Trial ID

NCT06125964

Start Date

October 6 2023

End Date

June 30 2024

Last Update

August 14 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Southern California

Los Angeles, California, United States, 90032